OnKure Therapeutics, Inc. Class A Common Stock (OKUR) is a publicly traded Healthcare sector company. As of July 28, 2026, OKUR trades at $4.12 with a market cap of $166.43M and a P/E ratio of -0.94. OKUR moved -2.01% today. Year to date, OKUR is +42.07%; over the trailing twelve months it is +73.84%. Its 52-week range spans $1.70 to $15.89. Analyst consensus is buy with an average price target of $23.00. Rallies surfaces OKUR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
OnKure Therapeutics, Inc. Class A Common Stock (OKUR) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. OKUR moved -2.01% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $4.12 |
| Market Cap | $166.43M |
| P/E Ratio | -0.94 |
| EPS | $-4.40 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.89 |
| 52-Week Low | $1.70 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.43M |
| Net Income | $-59.52M |
| Gross Margin | 0.00% |
3 analysts cover OKUR: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $23.00.